Oppenheimer USA | OPY - Cash And Equivalent


Oppenheimer USA reported $38.29M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Bank Of America USD 229.74B 20.12B Jun/2026
Barclays GBP 245.86B 10.51B Jun/2026
BGC Partners USD 780.98M 70.52M Mar/2026
Canaccord Genuity CAD 1.67B 356.41M Dec/2025
Citigroup USD 24.66B 361.06B Jun/2026
Deutsche Bank EUR 140.45B 9.42B Jun/2026
Evercore Partners USD 985.99M 440.03M Mar/2026
Goldman Sachs USD 187.27B 7.74B Jun/2026
JPMorgan USD 312.14B 31.2B Mar/2026
Matsui Securities JPY 825.16B 759.72B Mar/2026
Moelis & Company USD 207.74M 54.8M Jun/2026
Morgan Stanley USD 160.14B 26.61B Jun/2026
Oppenheimer USA USD 38.29M 670K Sep/2025
Piper Sandler Companies USD 344.43M 464.98M Mar/2026
Prospect Capital USD 34.59M 3.47M Mar/2026
Raymond James Financial USD 11.22B 1.33B Mar/2026
Reinet Investments EUR 0 0 Mar/2023
Stifel Financial USD 2.9B 645.58M Mar/2026
Transnational Corp Of Nigeria NGN 25.17B 6.49B Sep/2025
UMB Financial USD 5.61B 651.49M Jun/2026
Wells Fargo USD 203.38B 28.59B Jun/2026
XP BRL 10.36B 2.06B Dec/2025